Venture capital firm

Novartis Bioventures

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

Write a review

Israel
Business
Commercial
Management
+5 more

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

Novartis Bioventures is a life sciences investor, operating as the Novartis Venture Fund. It makes equity investments in biotechnology and biopharma businesses, mainly those developing new therapeutics and platforms. The fund is not tied to one stage and invests from seed rounds through later financing.

What Novartis Bioventures does

Equity investment: capital for life sciences companies at seed and later stages.
Lead or co-lead roles: the fund often leads or shares the lead in a round.
Board involvement: its people take an active seat on the boards of portfolio companies.
Therapeutics focus: attention on unmet medical need, clinical impact, proprietary science and efficient use of capital.

Clients

Biotechnology and biopharma companies in North America, Europe and Israel.

Key facts

Regions: North America, Europe and Israel
Portfolio: more than 40 companies
Team offices: Cambridge (USA) and Basel, Switzerland

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Rankings

Novartis Bioventures is ranked on 1 TrustList ranking at #13.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Novartis Bioventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 1 ranking

#13of 20
Israel
It is one of 2 here listing medical and one of 3 here listing science.
Its profile: “Biotechnology and biopharma companies in North America, Europe and Israel.”
Of the 20 here, 4 also cover early stage and 4 also cover venture capital; 7 also work in Tel Aviv and 4 also work in Europe.
Behind KDC Media Fund, ahead of Novartis Venture Fund.

As of 2026-11-02. Organic ranks only; sponsored placements are never ranks. How TrustList ranks